Andre joined the Board of OSE in early 2020. Andre is an experienced deep tech adviser with a background in investment banking. He was previously Managing Director, Global Head of Equity Trading at Deutsche Bank, where he worked from 1994 to 2016. After leaving investment banking, Andre founded Braavos Capital, a venture capital firm investing in early to growth stages. He sits on the Board of Next Biosciences and was previously on the Boards of Deep Science Ventures, Sygnia Asset Management
and Genesis Genetics.
Andre sits on the boards of OSE portfolio companies Osler, SpyBiotech, and Wild Bioscience.
